The safety and efficacy of Rivastigmine plus memantine versus Rivastigmine monotherapy in mild to moderate Alzheimer's disease

被引：0
|
作者：
Figiel, GS [1 ]
Figiel, S [1 ]
机构：
[1] Emory Eastside Heritage Ctr, Snellville, GA USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2006年 / 54卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
下载
收藏
页码：S186 / S187
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of rivastigmine in patients with Alzheimer's disease:: international randomised controlled trial
    Rösler, M
    Anand, R
    Cicin-Sain, A
    Gauthier, S
    Agid, Y
    Dal-Bianco, P
    Stähelin, HB
    Hartman, R
    Gharabawi, M
    BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7184): : 633 - 638
  • [32] Efficacy and safety of Rivastigmine (Exelon) in Alzheimer's disease patients with vascular risk factors
    Kumar, V
    Sugaya, K
    Messina, J
    Veach, J
    NEUROLOGY, 1999, 52 (06) : A395 - A396
  • [33] A 12-month study of the efficacy of rivastigmine in patients with advanced moderate Alzheimer's disease
    Karaman, Y
    Erdogan, F
    Köseoglu, E
    Turan, T
    Ersoy, AÖ
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (01) : 51 - 56
  • [34] Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease
    Burns, A
    Spiegel, R
    Quarg, P
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (03) : 243 - 249
  • [35] Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease
    Nieto, Rachel A.
    Deardorff, William James
    Grossberg, George T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (06) : 861 - 870
  • [36] Dose Effects Associated with Rivastigmine Transdermal Patch in Patients with Mild-to-Moderate Alzheimer's Disease
    Grossberg, George T.
    Somogyi, Monique
    Meng, Xiangyi
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S121 - S122
  • [37] Rivastigmine in the treatment of Alzheimer's disease
    Deleu, D
    EUROPEAN NEUROLOGY, 2001, 46 (02) : 111 - 111
  • [38] Evaluation of rivastigmine in Alzheimer's disease
    Nguyen, Kevin
    Hoffman, Heidi
    Chakkamparambil, Binu
    Grossberg, George T.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) : 35 - 48
  • [39] Efficacy of rivastigmine on loss of appetite in patients with Alzheimer's disease
    Tsuno, N.
    Mori, T.
    Nakamura, Y.
    EUROPEAN PSYCHIATRY, 2017, 41 : S176 - S177
  • [40] Rivastigmine patch in the one-year treatment of mild to moderate Alzheimer's disease and Parkinson's disease dementia
    Chiu, Pai-Yi
    Lai, T-J.
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 : S189 - S189
12345